|
|
||||||||
1 Heart and Stroke Richard Lewar Center of Excellence, University of Toronto, Toronto, Ontario; 2 Division of Cellular & Molecular Biology, Toronto General Hospital Research Institute, Toronto, Ontario M5G 2C4; and 3 The Montreal Heart Institute, Montreal, Quebec H1T 1C8, Canada
| |
ABSTRACT |
|---|
|
|
|---|
The myogenic response (MR) may represent an important physiological parameter underlying arterial blood pressure (BP). We studied the effects of age, gender, and BP on the MR of mesenteric arteries from 8- to 52-wk-old mice. Increasing age and BP are associated with an increase in the perfusion pressure at which tone develops (myogenic set point). An inverse correlation exists between age and extent (magnitude) of the MR in male (r2 = 0.93, P = 0.0087) and female mice (r2 = 0.90, P = 0.013) as well as between BP and extent of the MR in male (r2 = 0.96, P = 0.0036) and female (r2 = 0.90, P = 0.014) mice. In contrast, the strength of the MR (slope of active diameter-pressure relationship) and phenylephrine-mediated constriction did not differ among these groups. Although gender had no effect on MR at any perfusion pressure or age, only male mice showed significant salt-induced hypertension and an associated increase in the set point and reduction in the extent of the MR. The set point and extent of the MR is linked to the in vivo pressure during development and experimental hypertension.
salt-induced hypertension
| |
INTRODUCTION |
|---|
|
|
|---|
HYPERTENSION IS THE MOST COMMON cardiovascular disease and an important risk factor for myocardial infarction, stroke, and renal failure (28). Although the basic abnormality in hypertension is increased peripheral resistance (9), the mechanisms underlying this reflect a combination of structural and functional factors. On a functional level, peripheral resistance is a balance between vasodilator and vasoconstrictor mechanisms of the vascular smooth muscle. The myogenic response in resistance vessels is characterized by vasoconstriction in response to an increase in intraluminal pressure and vasodilation on pressure alleviation. This phenomenon is a component of the autoregulation of blood flow and the establishment of basal vascular tone (reviewed in Refs. 3 and 43). As such, the myogenic response may represent an important physiological parameter in determining arterial blood pressure (BP). Although both normal development (aging) and male gender are associated with a higher incidence of elevated BP (22, 23), the relationship of these factors with the myogenic response has not been well explored.
To date, several studies have examined vasomotor responses in the mouse (2, 4-6, 14, 24, 30, 31, 39, 41, 42, 47, 50, 51) (reviewed in Ref. 8). In some studies (4-6, 8, 24, 39, 42, 47, 50, 51), transgenic and knockout technologies were used to study pathways that may affect cardiovascular physiology. However, many of these studies (5, 8, 42, 50) focused on conduit vessels such as the aorta and carotid artery, and few of these studies (14, 17, 27, 30, 31, 39, 51) explored the myogenic response. Indeed, only three examined myogenic tone in the mesenteric arterial system (17, 30, 39) and none addressed the issue of age-, gender-, and BP-dependent effects on the myogenic responses of these vessels.
An age-dependent loss of the extent (magnitude of change from passive to active vessel diameter at a given experimental perfusion pressure) of the myogenic response has been reported when comparing mesenteric arteries from swine 1-3 and 35-40 days old (36, 40). However, as development of these swine was also associated with increases in arterial BP (40), it is unclear as to whether the observed reductions in this feature of the myogenic response can be attributed to age-related processes other than increasing BP.
Similarly, although female gender-dependent reductions in the extent of the myogenic response have been described in mouse and rat cerebral arteries (13-15), rat muscle arterioles (19), and rat coronary arteries (49), whether these differences are specifically related to the female gender or gender-related differences in BP has not been examined.
Finally, BP-dependent alterations in the strength [slope of the active pressure-vessel diameter relationship (7)] of the myogenic response were described in spontaneously hypertensive rats (SHR), where weaker myogenic responses were observed in cerebral arteries obtained from SHR compared with normotensive Wistar-Kyoto (WKY) rats (38). However, other reports have shown either no change or increased strength and/or extent of the myogenic response in SHR, depending on the age of the animals or arteries studied (7, 12, 18, 21, 44).
Thus the interrelationships among age, gender, and BP and their effects on fundamental features of the myogenic response have not been well studied in any animal preparation. To directly test the hypotheses that increasing age, female gender, and experimental elevations in BP increase the perfusion pressure at which myogenic tone develops (the set point of the myogenic response) and reduce its extent and strength, we have employed perfusion pressure myography in isolated mesenteric arteries from wild-type C57BL/6 mice. Our data show that neither development- nor salt-dependent elevations in BP affect the strength of observed myogenic responses or phenylephrine-mediated vasoconstriction. By contrast, we observed a direct relationship between the resting in vivo BP and the set point at which myogenic tone develops and an inverse relationship between in vivo BP and the magnitude of the myogenic response at defined experimental perfusion pressures. As such, we establish a normal standard against which molecular genetic models of hypertension and/or altered myogenic responsiveness may be compared.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Animals. Male and female C57BL/6 mice were purchased from Charles River Laboratories (Montreal, Quebec, Canada) and housed under a 12:12-h light-dark cycle with normal chow and water ad libitum. In a separate series of experiments, 8-wk-old male and female mice were fed either a normal or a high-salt diet (8% NaCl). The Animal Care Committee of the Toronto General Hospital approved all animal procedures.
Systolic BP determination. Indirect tail-cuff measurements of systolic BP were obtained in anesthetized (100 mg/kg ip ketamine and 10 mg/kg ip xylazine) mice by use of a mouse tail monitor (Kent Scientific; Litchfield, CT). Mice were placed on a warming blanket (37°C), and 3-5 consistent measurements were obtained for each mouse. BP measurements were obtained weekly from 8 to 24 wk of age and then at 26, 28, 32, 36, and 52 wk of age.
Vessel harvest and determination of myogenic responses. Mice were killed by cervical dislocation. The entire intestine was grossly dissected from the mouse and placed in a petri dish bathed in ice-cold physiological saline solution (PSS). Vascular dissection was performed under a stereoscope. Mesenteric arteries (second order) were stored in ice-cold PSS for <6 h. A pressure myograph was used to determine vessel diameter (Living Systems Instrumentation; Burlington, VT). This device consists of a small PSS-filled chamber (5 ml) into which two fine, diametrically opposed, moveable glass pipettes protrude. Constant temperature (37°C) was afforded by a heating element and thermostat. Under a dissecting microscope, an artery was mounted onto the pipettes and secured with sutures. One pipette was fitted distally with a stopcock; the other was attached to a peristaltic pump. This pump pressurized the artery and allowed for real-time control of the luminal perfusion pressure. Measurements were performed with a video dimension analyzer (VDA) connected to a camera on an inverted microscope. This device furnished real-time diameter measurements of the blood vessel. A ruler calibrated to the television monitor was used to confirm measurements of the VDA. Once mounted, vessels were equilibrated at 20 mmHg for 30 min; the PSS was changed every 10 min. To determine myogenic responses, the luminal pressure was increased in 20-mmHg steps from 20 to 120 mmHg. At each pressure, a 5- to 10-min equilibration period was allowed, and the vessel diameter was noted after a steady state was reached. At the end of each experiment, the chamber medium was replaced with Ca2+-free PSS, and the passive diameter was recorded for each pressure between 20 and 120 mmHg in 20-mmHg steps.
The set point of the myogenic response was defined as the lowest perfusion pressure at which vasoconstriction was first observed. The strength of the myogenic response was defined as the slope of the active diameter-pressure relationship (7) from the set point to 120 mmHg of perfusion pressure. The extent of the myogenic response at a given perfusion pressure was defined as the magnitude of the percent myogenic tone (%MT) at that pressure. %MT was expressed by the active (AD) and passive vessel diameters (PD) such that %MT = [(PD
AD)/PD] · 100%.
To observe contractile responses to phenylephrine in the absence of
myogenic constriction, vessels were pressurized to 60 mmHg and allowed
to equilibrate for 30 min. At 60 mmHg, myogenic constriction did not
play a significant role in any age group examined (see Figs. 3 and 4).
After the basal diameter (BD) was recorded, a phenylephrine (1 nmol/l-30 µmol/l) concentration-response curve was constructed.
A 3- to 5-min equilibration period was allowed with each dose. The
percent constriction (%C) was calculated from the BD and the
constricted diameter (CD) at a given phenylephrine concentration, and
the maximal CD (MD) was observed such that %C = [(BD
CD)/(BD
MD)] · 100%.
Data analysis. All data are expressed as means ± SE. Statistical analysis was done using either one-way or two-way ANOVA with Bonferroni post hoc tests and Student's t-test where appropriate.
Solutions and chemicals. PSS was of the following composition (in mmol/l): 130 NaCl, 14.9 NaHCO3, 10.0 glucose, 4.70 KCl, 1.17 MgSO4, 1.18 KH2PO4, 1.60 CaCl2, and 0.027 EDTA. Ca2+-free solution was of identical composition with CaCl2 omitted and 1.00 mmol/l EGTA added. Both solutions were brought to pH 7.4 and aerated continuously with 12% O2-5% CO2-83% N2. Phenylephrine was made up daily in PSS and stored on ice.
| |
RESULTS |
|---|
|
|
|---|
Body weight, age, and BP.
Body weight was significantly correlated with age in both male
(r2 = 0.84, P < 0.001) and
female (r2 = 0.70, P < 0.001) mice (Fig. 1A). To
examine the relationship between BP and development, we assessed
systolic BP in both male and female mice ranging from 8 to 52 wk of
age. Systolic BP was significantly correlated with age in both male
(r2 = 0.38, P < 0.001) and
female (r2 = 0.26, P < 0.001) mice (Fig. 1B). Systolic BP was significantly increased in both male and female mice at 24, 36, and 52 wk of age
compared with 8-wk-old mice. No significant difference in systolic BP
was observed between 36 and 52 wk of age in either male or female mice
(Fig. 1B). In addition, a significant positive correlation was observed between systolic BP and body weight for both
male (r2 = 0.38, P < 0.001) and female (r2 = 0.21, P < 0.001) mice (Fig. 1C).
|
Myogenic responses as a function of age, gender, and BP. To examine the relationship among age, gender, and myogenic responses, we assessed active and passive mesenteric artery diameters from male and female mice at different ages and experimental perfusion pressures.
Although passive vessel diameters appeared to increase with age, no consistent development- or gender-dependent differences were observed (Fig. 2). However, an age-dependent increase in the set point of the myogenic response (the lowest perfusion pressure at which myogenic tone develops) was observed in both male and female mice (Fig. 3). No significant myogenic tone was observed in 36- or 52-wk-old mice of either sex (Fig. 3).
|
|
|
|
|
0.22 ± 0.06; normal:
0.26 ± 0.03, P = NS). In contrast to male mice,
female mice fed a high-salt diet for 7 wk did not develop hypertension
compared with age-matched female mice on a normal diet (high salt:
systolic BP 99.8 ± 10.1 mmHg, n = 4 vs. normal:
systolic BP 101.3 ± 8.7 mmHg, n = 5;
P = NS). The set point, extent, and strength of
myogenic tone development was not significantly different between
female mice fed a high-salt vs. normal diet (Fig. 7B and
data not shown).
|
Phenylephrine responsiveness in mesenteric arteries. To examine whether the decline in myogenic tone with age was a generalized defect in smooth muscle contractility, mesenteric arteries were subjected to cumulative phenylephrine concentrations of 1 nmol/l to 30 µmol/l. In male mice of all age groups, progressive vasoconstriction with phenylephrine followed a very similar course, yielding nearly identical dose response curves (data not shown). In mice 8, 24, 36, and 52 wk old, the EC50 values for phenylephrine were 79 ± 17, 81 ± 22, 88 ± 15, and 111 ± 14 nmol/l, respectively, and were not significantly different at any age group. The EC50 values for female mice were not significantly different at any age or from age-matched male values (data not shown). Similarly, in salt-induced hypertensive male mice, the reduction in extent of %MT was not associated with altered phenylephrine-mediated contractions (high-salt diet: EC50 88 ± 11 nmol/l, n = 5 vs. normal diet: EC50 61 ± 7 nmol/l, n = 4, P = NS).
| |
DISCUSSION |
|---|
|
|
|---|
In the present study, we studied the effects of development, gender, and BP on the set point, extent, and strength of the myogenic response in mesenteric arteries obtained from male and female C57BL/6 mice. We have demonstrated an age-dependent increase in the myogenic set point in mesenteric arteries. In both male and female mice, the minimum perfusion pressure at which significant myogenic vasoconstriction was observed increases with age (80 mmHg at 8 wk, 100 mmHg at 12 and 24 wk, and 120 mmHg at 36 wk). This increase in the myogenic set point with age (Figs. 3 and 4) also parallels a significant increase in systolic BP. Although this may in part reflect a maturation of the cardiovascular system, such that increases in BP during development are associated with elevations in the myogenic set point, it remains unclear as to whether this is mediated solely by increases in BP, an alternate age-dependent mechanism, or both.
To address this, we utilized an acquired (salt induced) form of hypertension. Although previous studies have demonstrated increased BP in SHR (33, 34) and C3HeB/FeJ and C57BL/6 mice (1, 46) after salt loading, others have shown a lack of salt-induced hypertension in normotensive rats (10, 37) and wild-type C57BL/6 mice (25, 29). In our study, 3 wk of a high-salt (8% NaCl) diet significantly increased systolic BP in male mice. As observed with developmental elevations in BP, salt-induced hypertension was associated with a significant increase in the myogenic set point and a reduction in the extent of the myogenic response (Fig. 7A). Previous studies (33) in mesenteric arteries of SHR also showed that after 8 wk of a high-salt diet, a significant increase in mean arterial pressure was associated with a near complete loss of myogenic tone. In contrast to the results we obtained in male mice, female mice did not develop elevated BP during an even longer duration (7 wk) of a high-salt diet, and maximal myogenic tone development was not significantly altered (Fig. 7B). The lack of salt-induced hypertension in female mice may in part be explained by increased nitric oxide production. Kiraku et al. (26) observed that feeding female mice a high-salt diet for 12 wk resulted in increased nitric oxide production and no change in systolic BP. Taken together, our examination of both developmental increases in BP and salt-induced hypertension strongly suggests that the basal in vivo BP may regulate myogenic responsiveness. Indeed, the antihypertensive effect of the female gender is also consistent with the premise that BP is the dominant factor regulating myogenic responses.
A recent study (40) examining the extent of myogenic tone development in 3- and 35-day-old mesenteric arteries from swine also observed an age-dependent decrease in this parameter. This age-dependent decrease in the extent of the myogenic response was associated with a modest increase (11 mmHg) in mean systemic arterial BP that was, however, not statistically significant in the small numbers of animals tested (n = 5) (40). Osol and Halpern (38) observed "weaker" (reduced strength) myogenic responses in cerebral arteries obtained from SHR compared with normotensive WKY rats. However, other reports have shown either no change or increased extent and/or strength of myogenic responses in SHR, depending on the age of the animals or arteries studied (7, 12, 18, 21, 44). Although a detailed comparison of these studies reveals some inconsistencies, together they appear to indicate that during the early stages of hypertension development (4-12 wk of age in SHR), myogenic responsiveness is enhanced in hypertensive animals but is "reset" to normal levels with established hypertension (~20 wk of age in SHR). If "resetting" of the myogenic response to elevations in BP is a physiological occurrence, then failure of this adaptation may lead to enhanced myogenic tone and further increases in BP. Therefore, genetic mouse models displaying enhanced myogenic tone could represent models of systemic hypertension. To this end, our study establishes a quantitative age- and gender-dependent relationship between BP and myogenic tone, to which mouse models of altered BP or vasomotor function can now be compared.
In our study, no myogenic tone was observed in mesenteric arteries from 52-wk-old mice at any perfusion pressure tested (20-120 mmHg). Aging is associated with functional and structural changes in both conduit and resistance arteries (11, 35) (reviewed in Ref. 32). If mouse mesenteric arteries become "stiffer" or less compliant during development, this may result in a failure to detect changes in intraluminal pressures. As such, the maximal perfusion pressure (120 mmHg) applied to mesenteric arteries from 52-wk-old mice may have been below the set point for the myogenic response. To address this, we performed a small series of experiments (n = 3) to assess the effect of higher perfusion pressures. It is important to note that higher perfusion pressures (140-200 mmHg) were not associated with any significant myogenic tone development in mesenteric arteries obtained from 52-wk-old mice (data not shown). These data suggest that 52-wk-old arteries may have a generalized defect in "sensing" intraluminal pressure in addition to other possible functional and structural changes that may occur with development.
To our knowledge, no studies have been performed that examined age-related changes in mouse mesenteric artery stiffness or compliance. In addition, no significant age-related aortic stiffening was observed when comparing 4- and 13-mo-old C57BL/6 mice (48). However, an age-related decreased in mesenteric artery compliance has been reported in rats when comparing 3- and 10-mo-old animals (52). Because we did not measure wall thickness in this study, we are unable to examine age-, gender-, or systolic BP-associated differences in wall thickness-to-lumen ratios as they may pertain to myogenic responses. However, other studies (20) have shown that increased wall thickness-to-lumen ratios of mesenteric arteries from SHR were not associated with altered myogenic tone development.
Because phenylephrine-mediated constriction did not change with age, the loss of myogenic responsiveness in older animals is not due to a generalized loss of smooth muscle contractility. The discrepancy between age-related effects on myogenic- versus phenylephrine-mediated vasoconstriction may in part be explained by the absence in electromechanical coupling (pressure-mediated vasoconstriction, e.g., myogenic tone) of factors known to enhance smooth muscle cell contractility in pharmacomechanical coupling (agonist-mediated vasoconstriction, i.e., phenylephrine) (45). Of note, phenylephrine-mediated vasoconstriction was examined only at a perfusion pressure of 60 mmHg (the highest pressure at which no myogenic tone was observed in any age group tested). Accordingly, an interaction between agonist-mediated constriction and %MT at higher perfusion pressures cannot be ruled out.
Gender- and/or hormonal-dependent differences in the myogenic response have been described in both mouse and rat blood vessels (13-15, 19, 49). The decrease in myogenic tone development in female mice is in part mediated by estrogen-induced nitric oxide release (14, 15, 19, 49). We did not observe significant gender-mediated differences in myogenic tone development in isolated mesenteric arteries. Although 8-wk-old female mice did demonstrate reduced %MT at 80 mmHg of perfusion pressure compared with age-matched male mice, this was not statistically significant. In addition, comparable %MT was observed in both male and female mice at 100 and 120 mmHg of perfusion pressure. The lack of significant gender-dependent differences in myogenic tone development in our study may depend on the vascular preparation examined. Although Pearce et al. (39) have shown that nitric oxide is important in the counteraction of myogenic tone in mouse mesenteric arteries, perhaps the contribution of estrogen-induced nitric oxide release is significantly less in the mouse mesenteric artery than in other vascular beds.
The C57BL/6 strain is a common genetic background widely employed as a wild-type control (16, 17, 24). We report here that in examining the myogenic response, age, BP, and, to a lesser extent, gender are important factors that need to be carefully evaluated. Such consideration will be of particular relevance to the study of vascular responses in transgenic and knockout models of hypertension.
| |
ACKNOWLEDGEMENTS |
|---|
M. Husain is a clinician-scientist of the Canadian Institutes of Health Research (CIHR) and was a recipient of infrastructure awards from the Canada Foundation for Innovation and the Ontario Research and Development Challenge Fund. These studies were supported by CIHR Grants CL42617 and MT14648 and Heart & Stroke Foundation of Ontario (HSFO) Grants NA3636 and NA4389. R. Gros was supported by a HSFO Fellowship and was a recipient of the Edward Christie Stevens and the Evelyn McGloin Fellowship Awards. R. Van Wert was supported by a Summer Studentship from the Canadian Hypertension Society and the John D. Schultz Science Student Scholarship from the HSFO. X. You was supported by a Fellowship from the Canadian Hypertension Society/Medical Research Council of Canada.
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: M. Husain, Toronto General Hospital, 200 Elizabeth St., EN12-221, Toronto, Ontario, Canada M5G 2C4 (E-mail: mansoor.husain{at}utoronto.ca).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 11 May 2001; accepted in final form 11 September 2001.
| |
REFERENCES |
|---|
|
|
|---|
1.
Carlson, SH,
and
Wyss JM.
Long-term telemetric recording of arterial pressure and heart rate in mice fed basal and high NaCl diets.
Hypertension
35:
E1-E5,
2000.
2.
Chotani, MA,
Flavahan S,
Mitra S,
Daunt D,
and
Flavahan NA.
Silent
2C-adrenergic receptors enable cold-induced vasoconstriction in cutaneous arteries.
Am J Physiol Heart Circ Physiol
278:
H1075-H1083,
2000
3.
Davis, MJ,
and
Hill MA.
Signaling mechanisms underlying the vascular myogenic response.
Physiol Rev
79:
387-423,
1999
4.
De Wit, C,
Roos F,
Bolz SS,
Kirchhoff S,
Kruger O,
Willecke K,
and
Pohl U.
Impaired conduction of vasodilation along arterioles in connexin40-deficient mice.
Circ Res
86:
649-655,
2000
5.
Didion, SP,
Sigmund CD,
and
Faraci FM.
Impaired endothelial function in transgenic mice expressing both human renin and human angiotensinogen.
Stroke
31:
760-765,
2000
6.
Ding, H,
Kubes P,
and
Triggle C.
Potassium- and acetylcholine-induced vasorelaxation in mice lacking endothelial nitric oxide synthase.
Br J Pharmacol
129:
1194-2000,
2000[Web of Science][Medline].
7.
Falcone, JC,
Granger HJ,
and
Meininger GA.
Enhanced myogenic activation in skeletal muscle arterioles from spontaneously hypertensive rats.
Am J Physiol Heart Circ Physiol
265:
H1847-H1855,
1993
8.
Faraci, FM,
and
Sigmund CD.
Vascular biology in genetically altered mice: smaller vessels, bigger insight.
Circ Res
85:
1214-1225,
1999
9.
Folkow, B.
Physiological aspects of primary hypertension.
Physiol Rev
62:
347-504,
1982
10.
Frisbee, JC,
Sylvester FA,
and
Lombard JH.
Contribution of extrinsic factors and intrinsic vascular alterations to reduced arteriolar reactivity with high-salt diet and hypertension.
Microcirculation
7:
281-289,
2000[Web of Science][Medline].
11.
Gaballa, MA,
Jacob CT,
Raya TE,
Liu J,
Simon B,
and
Goldman S.
Large artery remodeling during aging: biaxial passive and active stiffness.
Hypertension
32:
437-443,
1998
12.
Garcia, SR,
Izzard AS,
Heagerty AM,
and
Bund SJ.
Myogenic tone in coronary arteries from spontaneously hypertensive rats.
J Vasc Res
34:
109-116,
1997[Web of Science][Medline].
13.
Geary, GG,
Krause DN,
and
Duckles SP.
Gonadal hormones affect diameter of male rat cerebral arteries through endothelium-dependent mechanisms.
Am J Physiol Heart Circ Physiol
279:
H610-H618,
2000
14.
Geary, GG,
Krause DN,
and
Duckles SP.
Estrogen reduces mouse cerebral artery tone through endothelial NOS- and cyclooxygenase-dependent mechanisms.
Am J Physiol Heart Circ Physiol
279:
H511-H519,
2000
15.
Geary, GG,
Krause DN,
and
Duckles SP.
Estrogen reduces myogenic tone through a nitric oxide-dependent mechanism in rat cerebral arteries.
Am J Physiol Heart Circ Physiol
275:
H292-H300,
1998
16.
Gyurko, R,
Kuhlencordt P,
Fishman MC,
and
Huang PL.
Modulation of mouse cardiac function in vivo by eNOS and ANP.
Am J Physiol Heart Circ Physiol
278:
H971-H981,
2000
17.
Henrion, D,
Terzi F,
Matrougui K,
Duriez M,
Boulanger CM,
Colucci-Guyon E,
Babinet C,
Briand P,
Friedlander G,
Poitevin P,
and
Levy BI.
Impaired flow-induced dilation in mesenteric resistance arteries from mice lacking vimentin.
J Clin Invest
100:
2909-2914,
1997[Web of Science][Medline].
18.
Huang, A,
Sun D,
and
Koller A.
Endothelial dysfunction augments myogenic arteriolar constriction in hypertension.
Hypertension
22:
913-921,
1993
19.
Huang, A,
Sun D,
Koller A,
and
Kaley G.
Gender difference in myogenic tone of rat arterioles is due to estrogen-induced, enhanced release of NO.
Am J Physiol Heart Circ Physiol
272:
H1804-H1809,
1997
20.
Izzard, AS,
Bund SJ,
and
Heagerty AM.
Increased wall-lumen ratio of mesenteric vessels from the spontaneously hypertensive rat is not associated with increased contractility under isobaric conditions.
Hypertension
28:
604-608,
1996
21.
Izzard, AS,
Bund SJ,
and
Heagerty AM.
Myogenic tone in mesenteric arteries from spontaneously hypertensive rats.
Am J Physiol Heart Circ Physiol
270:
H1-H6,
1996
22.
Kannel, WB,
Hjortland MC,
McNamara PM,
and
Gordon T.
Menopause and risk of cardiovascular disease: the Framingham study.
Ann Intern Med
85:
447-452,
1976.
23.
Kannel, WB,
Wolf PA,
McGee DL,
Dawber TR,
McNamara P,
and
Castelli WP.
Systolic blood pressure, arterial rigidity, and risk of stroke. The Framingham study.
JAMA
245:
1225-1229,
1981
24.
Kaul, DK,
Liu XD,
Fabry ME,
and
Nagel RL.
Impaired nitric oxide-mediated vasodilation in transgenic sickle mouse.
Am J Physiol Heart Circ Physiol
278:
H1799-H1806,
2000
25.
Kennedy, CR,
Zhang Y,
Brandon S,
Guan Y,
Coffee K,
Funk CD,
Magnuson MA,
Oates JA,
Breyer MD,
and
Breyer RM.
Salt-sensitive hypertension and reduced fertility in mice lacking the prostaglandin EP2 receptor.
Nat Med
5:
217-220,
1999[Web of Science][Medline].
26.
Kiraku, J,
Nakamura T,
Sugiyama T,
Takahashi N,
Kuro-o M,
Fujii J,
and
Nagai R.
Dietary salt loading increases nitric oxide synthesis in transgenic mice overexpressing sodium-proton exchanger.
Jpn J Pharmacol
80:
181-183,
1999[Medline].
27.
Ku, DD,
Guo L,
Dai J,
Acuff CG,
and
Steinhelper ME.
Coronary vascular and endothelial reactivity changes in transgenic mice overexpressing atrial natriuretic factor.
Am J Physiol Heart Circ Physiol
271:
H2368-H2376,
1996
28.
Lifton, RP.
Molecular genetics of human blood pressure variation.
Science
272:
676-680,
1996[Abstract].
29.
Lopez, MJ,
Wong SK,
Kishimoto I,
Dubois S,
Mach V,
Friesen J,
Garbers DL,
and
Beuve A.
Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide.
Nature
378:
65-68,
1995[Medline].
30.
Loufrani, L,
Matrougui K,
Gorny D,
Duriez M,
Blanc I,
Levy BI,
and
Henrion D.
Flow (shear stress)-induced endothelium-dependent dilation is altered in mice lacking the gene encoding for dystrophin.
Circulation
103:
864-870,
2001
31.
Lui, AH,
McManus BM,
and
Laher I.
Endothelial and myogenic regulation of coronary artery tone in the mouse.
Eur J Pharmacol
410:
25-31,
2000[Web of Science][Medline].
32.
Marin, J.
Age-related changes in vascular responses: a review.
Mech Ageing Dev
79:
71-114,
1995[Web of Science][Medline].
33.
Matrougui, K,
Schiavi P,
Guez D,
and
Henrion D.
High sodium intake decreases pressure-induced (myogenic) tone and flow-induced dilation in resistance arteries from hypertensive rats.
Hypertension
32:
176-179,
1998
34.
Mervaala, EM,
Malmberg L,
Teravainen TL,
Lahteenmaki T,
Karjala K,
Paakkari I,
Porsti I,
Mest HJ,
Vapaatalo H,
and
Karppanen H.
Influence of different dietary salts on the cardiovascular and renal effects of moxonidine in spontaneously hypertensive rats.
Naunyn Schmiedebergs Arch Pharmacol
356:
107-114,
1997[Web of Science][Medline].
35.
Moreau, P,
d'Uscio LV,
and
Luscher TF.
Structure and reactivity of small arteries in aging.
Cardiovasc Res
37:
247-253,
1998
36.
Nankervis, CA,
Dunaway DJ,
and
Nowicki PT.
Determinants of terminal mesenteric artery resistance during the first postnatal month.
Am J Physiol Gastrointest Liver Physiol
280:
G678-G686,
2001
37.
Nurkiewicz, TR,
and
Boegehold MA.
Limitation of arteriolar myogenic activity by local nitric oxide: segment-specific effect of dietary salt.
Am J Physiol Heart Circ Physiol
277:
H1946-H1955,
1999
38.
Osol, G,
and
Halpern W.
Myogenic properties of cerebral blood vessels from normotensive and hypertensive rats.
Am J Physiol Heart Circ Physiol
249:
H914-H921,
1985
39.
Pearce, LL,
Gandley RE,
Han W,
Wasserloos K,
Stitt M,
Kanai AJ,
McLaughlin MK,
Pitt BR,
and
Levitan ES.
Role of metallothionein in nitric oxide signaling as revealed by a green fluorescent fusion protein.
Proc Natl Acad Sci USA
97:
477-482,
2000
40.
Reber, KM,
and
Nowicki PT.
Pressure and flow characteristics of terminal mesenteric arteries in postnatal intestine.
Am J Physiol Gastrointest Liver Physiol
274:
G290-G298,
1998
41.
Russell, A,
and
Watts S.
Vascular reactivity of isolated thoracic aorta of the C57BL/6J mouse.
J Pharmacol Exp Ther
294:
598-604,
2000
42.
Schildmeyer, LA,
Braun R,
Taffet G,
Debiasi M,
Burns AE,
Bradley A,
and
Schwartz RJ.
Impaired vascular contractility and blood pressure homeostasis in the smooth muscle
-actin null mouse.
FASEB J
14:
2213-2220,
2000
43.
Schubert, R,
and
Mulvany MJ.
The myogenic response: established facts and attractive hypotheses.
Clin Sci (Colch)
96:
313-326,
1999[Medline].
44.
Shibuya, J,
Ohyanagi M,
and
Iwasaki T.
Enhanced myogenic response in resistance small arteries from spontaneously hypertensive rats: relationship to the voltage-dependent calcium channel.
Am J Hypertens
11:
767-773,
1998[Web of Science][Medline].
45.
Somlyo, AP,
and
Somlyo AV.
Signal transduction and regulation in smooth muscle.
Nature
372:
231-236,
1994[Medline].
46.
Veress, AT,
Chong CK,
Field LJ,
and
Sonnenberg H.
Blood pressure and fluid-electrolyte balance in ANF-transgenic mice on high- and low-salt diets.
Am J Physiol Regulatory Integrative Comp Physiol
269:
R186-R192,
1995
47.
Waldron, GJ,
Ding H,
Lovren F,
Kubes P,
and
Triggle CR.
Acetylcholine-induced relaxation of peripheral arteries isolated from mice.
Br J Pharmacol
128:
653-658,
1999[Web of Science][Medline].
48.
Wang, YX,
Halks-Miller M,
Vergona R,
Sullivan ME,
Fitch R,
Mallari C,
Martin-McNulty B,
da Cunha V,
Freay A,
Rubanyi GM,
and
Kauser K.
Increased aortic stiffness assessed by pulse wave velocity in apolipoprotein E-deficient mice.
Am J Physiol Heart Circ Physiol
278:
H428-H434,
2000
49.
Wellman, GC,
Bonev AD,
Nelson MT,
and
Brayden JE.
Gender differences in coronary artery diameter involve estrogen, nitric oxide, and Ca2+-dependent K+ channels.
Circ Res
79:
1024-1030,
1996
50.
Yamashita, T,
Kawashima S,
Ohashi Y,
Ozaki M,
Rikitake Y,
Inoue N,
Hirata K,
Akita H,
and
Yokoyama M.
Mechanisms of reduced nitric oxide/cGMP-mediated vasorelaxation in transgenic mice overexpressing endothelial nitric oxide synthase.
Hypertension
36:
97-102,
2000
51.
Zaritsky, JJ,
Eckman DM,
Wellman GC,
Nelson MT,
and
Schwarz TL.
Targeted disruption of Kir2.1 and Kir2.2 genes reveals the essential role of the inwardly rectifying K+ current in K+-mediated vasodilation.
Circ Res
87:
160-166,
2000
52.
Zhang, Y,
Stewart KG,
and
Davidge ST.
Estrogen replacement reduces age-associated remodeling in rat mesenteric arteries.
Hypertension
36:
970-974,
2000
This article has been cited by other articles:
![]() |
L. S. Kang, S. Kim, J. M. Dominguez II, A. L. Sindler, G. M. Dick, and J. M. Muller-Delp Aging and muscle fiber type alter K+ channel contributions to the myogenic response in skeletal muscle arterioles J Appl Physiol, August 1, 2009; 107(2): 389 - 398. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Gombos, V. Wolan, K. McDonald, and D. G. Hemmings Impaired vascular function in mice with an active cytomegalovirus infection Am J Physiol Heart Circ Physiol, April 1, 2009; 296(4): H937 - H945. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. J. Lott, C. Hogeman, M. Herr, M. Bhagat, and L. I. Sinoway Sex differences in limb vasoconstriction responses to increases in transmural pressures Am J Physiol Heart Circ Physiol, January 1, 2009; 296(1): H186 - H194. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ban, M. H. Noyan-Ashraf, J. Hoefer, S.-S. Bolz, D. J. Drucker, and M. Husain Cardioprotective and Vasodilatory Actions of Glucagon-Like Peptide 1 Receptor Are Mediated Through Both Glucagon-Like Peptide 1 Receptor-Dependent and -Independent Pathways Circulation, May 6, 2008; 117(18): 2340 - 2350. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Douglas, M. Natalia Cruz, L. Poston, J.-A. Gustafsson, and K. Kublickiene Functional characterization and sex differences in small mesenteric arteries of the estrogen receptor- knockout mouse Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2008; 294(1): R112 - R120. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Pinaud, A. Bocquet, O. Dumont, K. Retailleau, C. Baufreton, R. Andriantsitohaina, L. Loufrani, and D. Henrion Paradoxical Role of Angiotensin II Type 2 Receptors in Resistance Arteries of Old Rats Hypertension, July 1, 2007; 50(1): 96 - 102. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lamont, C. Vial, R. J. Evans, and W. G. Wier P2X1 receptors mediate sympathetic postjunctional Ca2+ transients in mesenteric small arteries Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H3106 - H3113. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Didion, D. A. Kinzenbaw, L. I. Schrader, and F. M. Faraci Heterozygous CuZn Superoxide Dismutase Deficiency Produces a Vascular Phenotype With Aging Hypertension, December 1, 2006; 48(6): 1072 - 1079. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Bagnall, N. F. Kelland, F. Gulliver-Sloan, A. P. Davenport, G. A. Gray, M. Yanagisawa, D. J. Webb, and Y. V. Kotelevtsev Deletion of Endothelial Cell Endothelin B Receptors Does Not Affect Blood Pressure or Sensitivity to Salt Hypertension, August 1, 2006; 48(2): 286 - 293. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Hemmings, S. J. Williams, and S. T. Davidge Increased myogenic tone in 7-month-old adult male but not female offspring from rat dams exposed to hypoxia during pregnancy Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H674 - H682. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Martinez-Lemus, T. Crow, M. J. Davis, and G. A. Meininger {alpha}v{beta}3- and {alpha}5{beta}1-integrin blockade inhibits myogenic constriction of skeletal muscle resistance arterioles Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H322 - H329. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. J. Lott, M. D. Herr, and L. I. Sinoway Effects of age on brachial artery myogenic responses in humans Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2004; 287(3): R586 - R591. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Gros, T. Afroze, X.-M. You, G. Kabir, R. Van Wert, W. Kalair, A. E. Hoque, I. N. Mungrue, and M. Husain Plasma Membrane Calcium ATPase Overexpression in Arterial Smooth Muscle Increases Vasomotor Responsiveness and Blood Pressure Circ. Res., October 3, 2003; 93(7): 614 - 621. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |